Summary: Inhibition of nitric oxide (NO) synthesis induces vasoconstriction and reduction of the blood flow in the brain, indicating that basal release of NO provides a resting vasore laxant tone in the cerebral circulation, In the present study, the contractile effect of the NO synthase blocker N G -nitro-L arginine (100 fLmollL) in isolated rat middle cerebral arteries was attenuated markedly in the presence of the cyclooxygenase inhibitor indomethacin (5 fLmol/L), the thromboxane A2 syn- 
Summary: Inhibition of nitric oxide (NO) synthesis induces vasoconstriction and reduction of the blood flow in the brain, indicating that basal release of NO provides a resting vasore laxant tone in the cerebral circulation, In the present study, the contractile effect of the NO synthase blocker N G -nitro-L arginine (100 fLmollL) in isolated rat middle cerebral arteries was attenuated markedly in the presence of the cyclooxygenase inhibitor indomethacin (5 fLmol/L), the thromboxane A2 synInhibition of the L-arginine-nitric oxide (NO) pathway results in vasoconstriction and reduction of the blood flow in the brain, indicating that the basal release of NO is an important regulator of the cerebral circulation, pro viding a resting relaxant tone in the cerebrovascular bed (Faraci and Brian, 1994; Iadecola et aI., 1994) . This ef fect of basal NO production has been regarded generally as a direct relaxant action mediated by the activation of the soluble guanylyl cyclase in vascular smooth-muscle cells. However, recently it has been shown that, in con trast to the marked contractile effect of the NO synthase (NOS) inhibitor N G -nitro-L-arginine methyl ester, I H-thase inhibitor ridogrel (10 fLmol/L), or the thromboxane re ceptor antagonist leI 192605 (100 fLmol/L). These results in dicate that removal of the endogenous NO stimulates the re lease of thromboxane A2 in cerebral vessels and basal NO production regulates the resting cerebrovascular tone, at least in part, by suppressing thromboxane A2. Key Words: Middle cerebral artery-Nitric oxide-Thromboxane A2-Endothe lium-Vasoconstriction. 
METHODS
Adult male Wi star rats were exsanguinated rapidly under deep ether anesthesia. Ring segments of the MCA were pre pared for measurement of isometric force as described previ ously (Gorlach and Wahl, 1996) . Special care was taken to preserve the endothelium during preparation of the artery. The segments were transferred into 5-mL organ baths filled with a modified Krebs solution of the following composition (mmoll L): NaCI, 119; KCI, 4.6; NaH2P04, 1.2; CaCI2'2H20, 1.5; MgCl2'6H20, 1.2; NaHC03, 15; and glucose, 10. The bath solution was bubbled continuously with a humidified gas mix ture (90% 02� 10% CO2), The MCA segments were mounted on two L-shaped tungsten wires (50 fLm diameter) one of which was fixed to the bath whereas the second one was connected to a force transducer for measuring isometric force. The vessels were allowed a 90-minute equilibration period, during which the resting tension was adjusted to 1.5 mN. Thereafter each segment was exposed to a 124-mmollL K+ Krebs solution to elicit a reference contraction. After a 60-minute resting period, the functional integrity of the endothelium was tested by ap plication of bradykinin (0.01-10 fLmollL, Calbiochem, Bad Soden, Germany) after precontraction induced by 100 fLmollL UTP (Serva, Heidelberg, Germany). Segments that did not show at least 20% relaxation of the precontraction were ex cluded from the study. The dilator effect of I fLmollL brady kinin in endothelium-intact vessels was 36.5 ± 17.8% of the UTP precontraction, which was 1.12 ± 0.28 mN. After a 60-minute resting period, the effect of 100 fLmol/L L-NA (Sigma [Deisenhofen, Germany] dissolved in saline) on the resting tone of the vessel rings was determined 15 minutes after its application in the absence or presence of the cyclooxygen ase inhibitor indomethacin (5 fLmol/L, Sigma), the throm boxane A2 synthase inhibitor ridogrel «E)-5- [[[3-pyridinil[3-(trifluoromethyl) < Z I � drugs, or their vehicles, were applied 12 minutes before the administration of L-NA. L-NA was used in a concentration (100 fLmollL) that completely abolishes the endothelium dependent dilator effect of bradykinin in rat MCAs (Gorlach and Wahl, 1996) . Indomethacin and ridogrel were dissolved in 2% Na2C03 and 400 mmollL NaOH, respectively and diluted with saline. ICI 192605 was dissolved in DMSO (Aldrich, Mil waukee, WI, U.S.A.). Ridogrel is described as having both thromboxane A2 synthase inhibitor activity and antagonistic activity at the common receptor for thromboxane A2 and its precursor prostaglandin H2 (De Clerck et al., 1989) . However, in the present experiments�according to the study of Descombes et a!. (1993) �ridogrel is considered to act as a thromboxane A2 synthase inhibitor, because the concentration of ridogrel selected (10 fLmollL) is lower than its ICso value at thromboxane receptors (De Clerck et a!., 1989) . Nevertheless, we can not exclude the possibility that ridogrel also antagonizes the action of prostaglandin H2, and therefore findings in the present study relating to the release of thromboxane A2 also refer to prostaglandin H2.
All values in the text and figure are presented as the mean (± SD) percentage of the reference contraction induced by 124 mmollL K+ Krebs solution. The contractile effect of 124 mmollL K+ Krebs solution in absolute terms was 2.14 ± 0.70 mN. The number of MCA segments studied is expressed by n. Results were analyzed statistically using either Student's t-test or one-way analysis of variance followed by Fisher's protected least-significant difference test. A P value less than 0.05 was considered significant.
RESULTS AND DISCUSSION
The vehicles for indomethacin, ridogrel, or ICI 192605 had no significant effect on the resting tone of the MCA segments (-0.3 ± 1.7%, -0. 1 ± 0.3% and -0.2 ± 0.8%, respectively, n = ll-19). In contrast, a weak, but significant (P < 0.005), reduction of the vascular tension was observed after administration of indometh acin (-2.7 ± 3.6%, n = 21), ridogrel (-1. 1 ± 1.0%, n = 22), or ICI 192605 (-3.4 ± 3.0%, n = 20). The contract ** tt *** tile effect of L-NA was not altered in vehicle-treated segments when compared with untreated controls (Fig.   1) . However, treatment with indomethacin, ridogrel, or ICI 192605, markedly attenuated the L-NA-induced con tractions (Fig. l) . In conclusion, the present results are the first indica tion that the basal NO production suppresses the release of thromboxane A2 in rat MCAs and that this interaction plays an important role in the maintenance of the resting cerebrovascular tone. Further studies are needed to in vestigate the presence of a similar action of NO in other vascular beds and platelets.
